CVKD
Cadrenal Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website cadrenal.com
- Employees(FY) 3
- ISIN US1276361086
Performance
-15.33%
1W
+5.41%
1M
-48.63%
3M
-8.87%
6M
-44.45%
YTD
-71.06%
1Y
Profile
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Technical Analysis of CVKD 2024-05-10
Overview:
In analyzing the technical indicators for CVKD stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key indicators such as moving averages, MACD, RSI, Stochastic Oscillator, Bollinger B...
Recent News & Updates
- 2024-05-09 01:53
- 2024-05-08 21:00
- 2024-04-11 04:30
- 2024-04-08 21:00
- 2024-03-10 21:00
- 2024-02-25 20:00
- 2024-02-07 20:00
- 2024-01-30 20:00
- 2024-01-23 20:00
- 2024-01-03 20:00
- 2023-12-18 20:00
- 2023-12-11 20:00
- 2023-11-30 03:15
- 2023-11-08 20:00
- 2023-10-15 20:38
- 2023-10-09 04:15
- 2023-09-04 20:00
- 2023-08-29 20:00
- 2023-08-28 04:15
- 2023-08-09 21:00
- 2023-07-31 21:00
- 2023-07-23 21:00
- 2023-07-14 03:02
- 2023-07-12 03:17
- 2023-06-27 18:23
The 3 Hottest IPOs to Buy Before They Soar(Yahoo Finance)
- 2023-05-31 21:00
- 2023-05-09 21:00
- 2023-05-09 04:30
- 2023-03-29 21:00
- 2023-03-08 20:00
Page 1 of 2
previousnext